Computational tools and new strategies make drug discovery m
Drug researchers have traditionally relied on high-throughput screening, in which small arrays of compounds are tested against a target. This method depends on finding more molecules to test, and it can be time-consuming and costly. To address the need for more molecules, companies are growing their physical and virtual libraries of compounds. The chemical industry has only scratched the surface of possible molecules that could be used as drugs, which is unimaginably greater than the number of stars in the universe. To make navigating this vast chemical space more manageable, researchers are using new computational tools that make the process cheaper and more efficient.